0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Spine Biologics Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-7224
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Spine Biologics Market Insights Forecast to 2025
BUY CHAPTERS

Global Spine Biologics Market Research Report 2024

Code: QYRE-Auto-7224
Report
February 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Spine Biologics Market Size

The global Spine Biologics market was valued at US$ 2363 million in 2023 and is anticipated to reach US$ 2974 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Spine Biologics Market

Spine Biologics Market

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.
North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.
In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.
This report aims to provide a comprehensive presentation of the global market for Spine Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Biologics.

Report Scope

The Spine Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spine Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spine Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Spine Biologics Market Report

Report Metric Details
Report Name Spine Biologics Market
Accounted market size in 2023 US$ 2363 million
Forecasted market size in 2030 US$ 2974 million
CAGR 3.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Bone Graft
  • Bone Graft Substitute
  • Platelet Rich Plasma (PRP)
  • BMAC (Bone Marrow Aspirate Concentrate)
Segment by Application
  • Anterior Cervical Discectomy and Fusion
  • Posterior Lumbar Interbody Fusion
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Spine Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Spine Biologics Market growing?

Ans: The Spine Biologics Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Spine Biologics Market size in 2030?

Ans: The Spine Biologics Market size in 2030 will be US$ 2974 million.

What is the market share of major companies in Spine Biologics Market?

Ans: Global top five manufacturers hold a share over 75%.

What is the Spine Biologics Market share by type?

Ans: In terms of product, Bone Graft is the largest segment, with a share over 55%.

Who are the main players in the Spine Biologics Market report?

Ans: The main players in the Spine Biologics Market are Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex

What are the Application segmentation covered in the Spine Biologics Market report?

Ans: The Applications covered in the Spine Biologics Market report are Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion, Others

What are the Type segmentation covered in the Spine Biologics Market report?

Ans: The Types covered in the Spine Biologics Market report are Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), BMAC (Bone Marrow Aspirate Concentrate)

1 Spine Biologics Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Spine Biologics Segment by Type
1.2.1 Global Spine Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Spine Biologics Segment by Application
1.3.1 Global Spine Biologics Market Value by Application: (2024-2030)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size Estimates and Forecasts
1.4.1 Global Spine Biologics Revenue 2019-2030
1.4.2 Global Spine Biologics Sales 2019-2030
1.4.3 Global Spine Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Spine Biologics Market Competition by Manufacturers
2.1 Global Spine Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Spine Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Spine Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Spine Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Spine Biologics, Product Type & Application
2.7 Spine Biologics Market Competitive Situation and Trends
2.7.1 Spine Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Spine Biologics Players Market Share by Revenue
2.7.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Spine Biologics Retrospective Market Scenario by Region
3.1 Global Spine Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Spine Biologics Global Spine Biologics Sales by Region: 2019-2030
3.2.1 Global Spine Biologics Sales by Region: 2019-2024
3.2.2 Global Spine Biologics Sales by Region: 2025-2030
3.3 Global Spine Biologics Global Spine Biologics Revenue by Region: 2019-2030
3.3.1 Global Spine Biologics Revenue by Region: 2019-2024
3.3.2 Global Spine Biologics Revenue by Region: 2025-2030
3.4 North America Spine Biologics Market Facts & Figures by Country
3.4.1 North America Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Spine Biologics Sales by Country (2019-2030)
3.4.3 North America Spine Biologics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Spine Biologics Market Facts & Figures by Country
3.5.1 Europe Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Spine Biologics Sales by Country (2019-2030)
3.5.3 Europe Spine Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Spine Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Spine Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Spine Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Spine Biologics Market Facts & Figures by Country
3.7.1 Latin America Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Spine Biologics Sales by Country (2019-2030)
3.7.3 Latin America Spine Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Spine Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Spine Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Spine Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Spine Biologics Sales by Type (2019-2030)
4.1.1 Global Spine Biologics Sales by Type (2019-2024)
4.1.2 Global Spine Biologics Sales by Type (2025-2030)
4.1.3 Global Spine Biologics Sales Market Share by Type (2019-2030)
4.2 Global Spine Biologics Revenue by Type (2019-2030)
4.2.1 Global Spine Biologics Revenue by Type (2019-2024)
4.2.2 Global Spine Biologics Revenue by Type (2025-2030)
4.2.3 Global Spine Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Spine Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Spine Biologics Sales by Application (2019-2030)
5.1.1 Global Spine Biologics Sales by Application (2019-2024)
5.1.2 Global Spine Biologics Sales by Application (2025-2030)
5.1.3 Global Spine Biologics Sales Market Share by Application (2019-2030)
5.2 Global Spine Biologics Revenue by Application (2019-2030)
5.2.1 Global Spine Biologics Revenue by Application (2019-2024)
5.2.2 Global Spine Biologics Revenue by Application (2025-2030)
5.2.3 Global Spine Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Spine Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Spine Biologics Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Depuy Synthes
6.2.1 Depuy Synthes Corporation Information
6.2.2 Depuy Synthes Description and Business Overview
6.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Depuy Synthes Spine Biologics Product Portfolio
6.2.5 Depuy Synthes Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Corporation Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Corporation Spine Biologics Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Nuvasive
6.4.1 Nuvasive Corporation Information
6.4.2 Nuvasive Description and Business Overview
6.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nuvasive Spine Biologics Product Portfolio
6.4.5 Nuvasive Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zimmer Biomet Spine Biologics Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Orthofix International
6.6.1 Orthofix International Corporation Information
6.6.2 Orthofix International Description and Business Overview
6.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Orthofix International Spine Biologics Product Portfolio
6.6.5 Orthofix International Recent Developments/Updates
6.7 Globus Medical
6.6.1 Globus Medical Corporation Information
6.6.2 Globus Medical Description and Business Overview
6.6.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Globus Medical Spine Biologics Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 alphatec spine
6.8.1 alphatec spine Corporation Information
6.8.2 alphatec spine Description and Business Overview
6.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 alphatec spine Spine Biologics Product Portfolio
6.8.5 alphatec spine Recent Developments/Updates
6.9 K2M
6.9.1 K2M Corporation Information
6.9.2 K2M Description and Business Overview
6.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 K2M Spine Biologics Product Portfolio
6.9.5 K2M Recent Developments/Updates
6.10 Exactech
6.10.1 Exactech Corporation Information
6.10.2 Exactech Description and Business Overview
6.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Exactech Spine Biologics Product Portfolio
6.10.5 Exactech Recent Developments/Updates
6.11 Wright Medical Technology
6.11.1 Wright Medical Technology Corporation Information
6.11.2 Wright Medical Technology Spine Biologics Description and Business Overview
6.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wright Medical Technology Spine Biologics Product Portfolio
6.11.5 Wright Medical Technology Recent Developments/Updates
6.12 X-Spine
6.12.1 X-Spine Corporation Information
6.12.2 X-Spine Spine Biologics Description and Business Overview
6.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 X-Spine Spine Biologics Product Portfolio
6.12.5 X-Spine Recent Developments/Updates
6.13 Nutech
6.13.1 Nutech Corporation Information
6.13.2 Nutech Spine Biologics Description and Business Overview
6.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nutech Spine Biologics Product Portfolio
6.13.5 Nutech Recent Developments/Updates
6.14 Arthrex
6.14.1 Arthrex Corporation Information
6.14.2 Arthrex Spine Biologics Description and Business Overview
6.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Arthrex Spine Biologics Product Portfolio
6.14.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Spine Biologics Industry Chain Analysis
7.2 Spine Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Spine Biologics Production Mode & Process
7.4 Spine Biologics Sales and Marketing
7.4.1 Spine Biologics Sales Channels
7.4.2 Spine Biologics Distributors
7.5 Spine Biologics Customers
8 Spine Biologics Market Dynamics
8.1 Spine Biologics Industry Trends
8.2 Spine Biologics Market Drivers
8.3 Spine Biologics Market Challenges
8.4 Spine Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Spine Biologics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Spine Biologics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Spine Biologics Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Spine Biologics Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Spine Biologics Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Spine Biologics Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Spine Biologics Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Spine Biologics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Spine Biologics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Spine Biologics, Product Type & Application
    Table 12. Global Key Manufacturers of Spine Biologics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Spine Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Spine Biologics Sales by Region (2019-2024) & (K Units)
    Table 18. Global Spine Biologics Sales Market Share by Region (2019-2024)
    Table 19. Global Spine Biologics Sales by Region (2025-2030) & (K Units)
    Table 20. Global Spine Biologics Sales Market Share by Region (2025-2030)
    Table 21. Global Spine Biologics Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Spine Biologics Revenue Market Share by Region (2019-2024)
    Table 23. Global Spine Biologics Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Spine Biologics Revenue Market Share by Region (2025-2030)
    Table 25. North America Spine Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Spine Biologics Sales by Country (2019-2024) & (K Units)
    Table 27. North America Spine Biologics Sales by Country (2025-2030) & (K Units)
    Table 28. North America Spine Biologics Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Spine Biologics Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Spine Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Spine Biologics Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Spine Biologics Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Spine Biologics Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Spine Biologics Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Spine Biologics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Spine Biologics Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Spine Biologics Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Spine Biologics Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Spine Biologics Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Spine Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Spine Biologics Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Spine Biologics Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Spine Biologics Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Spine Biologics Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Spine Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Spine Biologics Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Spine Biologics Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Spine Biologics Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Spine Biologics Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Spine Biologics Sales (K Units) by Type (2019-2024)
    Table 51. Global Spine Biologics Sales (K Units) by Type (2025-2030)
    Table 52. Global Spine Biologics Sales Market Share by Type (2019-2024)
    Table 53. Global Spine Biologics Sales Market Share by Type (2025-2030)
    Table 54. Global Spine Biologics Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Spine Biologics Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Spine Biologics Revenue Market Share by Type (2019-2024)
    Table 57. Global Spine Biologics Revenue Market Share by Type (2025-2030)
    Table 58. Global Spine Biologics Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Spine Biologics Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Spine Biologics Sales (K Units) by Application (2019-2024)
    Table 61. Global Spine Biologics Sales (K Units) by Application (2025-2030)
    Table 62. Global Spine Biologics Sales Market Share by Application (2019-2024)
    Table 63. Global Spine Biologics Sales Market Share by Application (2025-2030)
    Table 64. Global Spine Biologics Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Spine Biologics Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Spine Biologics Revenue Market Share by Application (2019-2024)
    Table 67. Global Spine Biologics Revenue Market Share by Application (2025-2030)
    Table 68. Global Spine Biologics Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Spine Biologics Price (USD/Unit) by Application (2025-2030)
    Table 70. Medtronic Corporation Information
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Medtronic Spine Biologics Product
    Table 74. Medtronic Recent Developments/Updates
    Table 75. Depuy Synthes Corporation Information
    Table 76. Depuy Synthes Description and Business Overview
    Table 77. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Depuy Synthes Spine Biologics Product
    Table 79. Depuy Synthes Recent Developments/Updates
    Table 80. Stryker Corporation Corporation Information
    Table 81. Stryker Corporation Description and Business Overview
    Table 82. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Stryker Corporation Spine Biologics Product
    Table 84. Stryker Corporation Recent Developments/Updates
    Table 85. Nuvasive Corporation Information
    Table 86. Nuvasive Description and Business Overview
    Table 87. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Nuvasive Spine Biologics Product
    Table 89. Nuvasive Recent Developments/Updates
    Table 90. Zimmer Biomet Corporation Information
    Table 91. Zimmer Biomet Description and Business Overview
    Table 92. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Zimmer Biomet Spine Biologics Product
    Table 94. Zimmer Biomet Recent Developments/Updates
    Table 95. Orthofix International Corporation Information
    Table 96. Orthofix International Description and Business Overview
    Table 97. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Orthofix International Spine Biologics Product
    Table 99. Orthofix International Recent Developments/Updates
    Table 100. Globus Medical Corporation Information
    Table 101. Globus Medical Description and Business Overview
    Table 102. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Globus Medical Spine Biologics Product
    Table 104. Globus Medical Recent Developments/Updates
    Table 105. alphatec spine Corporation Information
    Table 106. alphatec spine Description and Business Overview
    Table 107. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. alphatec spine Spine Biologics Product
    Table 109. alphatec spine Recent Developments/Updates
    Table 110. K2M Corporation Information
    Table 111. K2M Description and Business Overview
    Table 112. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. K2M Spine Biologics Product
    Table 114. K2M Recent Developments/Updates
    Table 115. Exactech Corporation Information
    Table 116. Exactech Description and Business Overview
    Table 117. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Exactech Spine Biologics Product
    Table 119. Exactech Recent Developments/Updates
    Table 120. Wright Medical Technology Corporation Information
    Table 121. Wright Medical Technology Description and Business Overview
    Table 122. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Wright Medical Technology Spine Biologics Product
    Table 124. Wright Medical Technology Recent Developments/Updates
    Table 125. X-Spine Corporation Information
    Table 126. X-Spine Description and Business Overview
    Table 127. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. X-Spine Spine Biologics Product
    Table 129. X-Spine Recent Developments/Updates
    Table 130. Nutech Corporation Information
    Table 131. Nutech Description and Business Overview
    Table 132. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. Nutech Spine Biologics Product
    Table 134. Nutech Recent Developments/Updates
    Table 135. Arthrex Corporation Information
    Table 136. Arthrex Description and Business Overview
    Table 137. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 138. Arthrex Spine Biologics Product
    Table 139. Arthrex Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Spine Biologics Distributors List
    Table 143. Spine Biologics Customers List
    Table 144. Spine Biologics Market Trends
    Table 145. Spine Biologics Market Drivers
    Table 146. Spine Biologics Market Challenges
    Table 147. Spine Biologics Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Spine Biologics
    Figure 2. Global Spine Biologics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Spine Biologics Market Share by Type in 2023 & 2030
    Figure 4. Bone Graft Product Picture
    Figure 5. Bone Graft Substitute Product Picture
    Figure 6. Platelet Rich Plasma (PRP) Product Picture
    Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
    Figure 8. Global Spine Biologics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Spine Biologics Market Share by Application in 2023 & 2030
    Figure 10. Anterior Cervical Discectomy and Fusion
    Figure 11. Posterior Lumbar Interbody Fusion
    Figure 12. Others
    Figure 13. Global Spine Biologics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Spine Biologics Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Spine Biologics Sales (2019-2030) & (K Units)
    Figure 16. Global Spine Biologics Average Price (USD/Unit) & (2019-2030)
    Figure 17. Spine Biologics Report Years Considered
    Figure 18. Spine Biologics Sales Share by Manufacturers in 2023
    Figure 19. Global Spine Biologics Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Spine Biologics Players: Market Share by Revenue in 2023
    Figure 21. Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Spine Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Spine Biologics Sales Market Share by Country (2019-2030)
    Figure 24. North America Spine Biologics Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Spine Biologics Sales Market Share by Country (2019-2030)
    Figure 28. Europe Spine Biologics Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Spine Biologics Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Spine Biologics Revenue Market Share by Region (2019-2030)
    Figure 36. China Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Spine Biologics Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Spine Biologics Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Spine Biologics Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Spine Biologics Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Spine Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Spine Biologics by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Spine Biologics by Type (2019-2030)
    Figure 57. Global Spine Biologics Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Spine Biologics by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Spine Biologics by Application (2019-2030)
    Figure 60. Global Spine Biologics Price (USD/Unit) by Application (2019-2030)
    Figure 61. Spine Biologics Value Chain
    Figure 62. Spine Biologics Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS